Industry-leading margins, a distribution machine being actively strengthened, and an embedded value that has grown through Covid, regulation and everything else — Emkay reiterates BUY
Not many financial businesses can point to twenty percent embedded value compounding over ten years — through a pandemic, multiple regulatory disruptions, and shifting product landscapes — without raising a single rupee of fresh capital. SBI Life can. And the fourth quarter of FY26 added another steady chapter to that record, with the company delivering margins that beat both consensus and Emkay’s own estimates, driven by strong growth in pure protection products and a product mix that continues to improve.
Margin phase
In life insurance, Value of New Business margin is the metric that serious analysts watch most closely — it captures the profitability of new policies written, and it is notoriously hard to sustain at high levels as a company scales. SBI Life’s Q4 VNB margin came in at 28.3%, ahead of consensus expectations of 28% and Emkay’s estimate of 27.4%. “The company delivered an industry-leading VNB margin despite the impact of GST ITC losses,” Emkay notes in its report, attributing the beat to robust growth in the pure-protection segment and a favourable product mix.
For the full year FY26, VNB margin settled at 27.5% — a 30 basis point decline year-on-year, but still 20 basis points ahead of Emkay’s estimate. The embedded value came in at Rs 807.9 billion, 2.6% above estimate, aided by a low impact from negative economic variance. These are not dramatic beats — they are the kind of consistent, modest outperformance that a compounding business tends to produce quarter after quarter.
Growth Broadens
SBI Life’s bancassurance relationship with State Bank of India has always been its most visible distribution advantage — a channel that gives it access to the largest branch network in the country. That channel is expected to continue growing at 10-11%. But the more interesting strategic development is what the company is building in parallel.
Management has spent the last several quarters actively strengthening the agency channel — adding branches, recruiting new agents, and improving agent productivity. These initiatives are now expected to be the primary driver of incremental growth in FY27. The logic is sound: a business that can grow through both its banca relationship and an expanding agency force is a more resilient compounder than one relying on a single channel.
Management has guided for approximately 14% APE growth in FY27, with VNB margin expected to remain rangebound at 27-28%. The margin guidance is conservative by design — the company is prioritising product mix improvement as the lever for any expansion, rather than volume-driven margin dilution.
Compounding Machine
The statistic that Emkay leads with in its valuation section is worth sitting with. “Despite a decade full of external volatilities — Covid-19, regulatory disruptions — SBIL saw EV CAGR of approximately 20% over FY16-26 without any capital raise,” the report says. That is the kind of sentence that deserves to be read slowly. Twenty percent compounding in embedded value, self-funded, through everything the last decade threw at Indian financial services.
Emkay raises its APE estimate by approximately 1% and its VNB margin estimate by 20 basis points following the Q4 results, leading to a 1-2% increase in VNB estimates over FY27-28. It also introduces FY29 estimates for the first time. The BUY rating is reiterated with an unchanged target of Rs 2,250 — implying 19% upside from the current market price — at 2.0x FY28 embedded value.
The Case
SBI Life is not a stock that makes headlines for dramatic quarterly swings. It makes headlines, quietly and reliably, for doing the same thing well over long periods — writing profitable policies, compounding embedded value, and steadily extending its distribution reach. For investors looking at the insurance sector, Emkay’s note is a reminder that the most durable stories in financial services are often the least exciting ones to describe.